| Report Title | Price | Action |
|---|---|---|
| Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021
Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 Summary Aortic Valve Stenosis (Cardiovascular) - Drugs in Development, 2021 prov...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| 5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021
5-Hydroxytryptamine Receptor 1B (5 HT1B or S12 or Serotonin 1D Beta Receptor or Serotonin Receptor 1B or HTR1B) - Drugs in Development, 2021 Summary ...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose Transferase or ADP Ribosyl Cyclase 1 or CD38 or EC 3.2.2.6 or EC 2.4.99.20) - Drugs in Development, 2021
ADP Ribosyl Cyclase/Cyclic ADP Ribose Hydrolase 1 (Cyclic ADP Ribose Hydrolase 1 or T10 or 2' Phospho ADP Ribosyl Cyclase/2' Phospho Cyclic ADP Ribose...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021
Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021 Summary Caspase (CASP or EC 3.4.22.) - Drugs in Development, 2021 provides in depth analys...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Cardiovascular Risk Factors (Cardiovascular) - Drugs in Development, 2021
Cardiovascular Risk Factors (Cardiovascular) - Drugs in Development, 2021 Summary Cardiovascular Risk Factors (Cardiovascular) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Fc Fragment Of IgG Low Affinity III Receptor (CD16 or FCGR3) - Drugs in Development, 2021
Fc Fragment Of IgG Low Affinity III Receptor (CD16 or FCGR3) - Drugs in Development, 2021 Summary Fc Fragment Of IgG Low Affinity III Receptor (CD16...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Cells Expressing NKG2 D Type II Integral Membrane Protein (Killer Cell Lectin Like Receptor Subfamily K Member 1 or NK Cell Receptor D or NKG2D Activating NK Receptor or CD314 or NKG2D or KLRK1) - Drugs in Development, 2021
Cells Expressing NKG2 D Type II Integral Membrane Protein (Killer Cell Lectin Like Receptor Subfamily K Member 1 or NK Cell Receptor D or NKG2D Activa...
Published: Apr-2021 | No. of Pages: 50
|
$ 3000 | |
| CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021
CD276 Antigen (B7 Homolog 3 or 4Ig B7 H3 or Costimulatory Molecule or CD276) - Drugs in Development, 2021 Summary CD276 Antigen (B7 Homolog 3 or 4Ig...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021
Anorexia Nervosa (Central Nervous System) - Drugs in Development, 2021 Summary Anorexia Nervosa (Central Nervous System) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Interleukin 6 (B Cell Stimulatory Factor 2 or BSF2 or CTL Differentiation Factor or CDF or Hybridoma Growth Factor or Interferon Beta 2 or IFNB2 or IL6) - Drugs in Development, 2021
Interleukin 6 (B Cell Stimulatory Factor 2 or BSF2 or CTL Differentiation Factor or CDF or Hybridoma Growth Factor or Interferon Beta 2 or IFNB2 or IL...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Cell Division Control Protein 42 Homolog (G25K GTP Binding Protein or Small GTP Binding Protein CDC42 or CDC42) - Drugs in Development, 2021
Cell Division Control Protein 42 Homolog (G25K GTP Binding Protein or Small GTP Binding Protein CDC42 or CDC42) - Drugs in Development, 2021 Summary ...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021
Appetite (Eating) Disorders (Central Nervous System) - Drugs in Development, 2021 Summary Appetite (Eating) Disorders (Central Nervous System) - Dru...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or PTGIR) - Drugs in Development, 2021
Prostacyclin Receptor (Prostaglandin I2 Receptor or Prostanoid IP Receptor or PTGIR) - Drugs in Development, 2021 Summary Prostacyclin Receptor (Pro...
Published: Apr-2021 | No. of Pages: 55
|
$ 3000 | |
| Small-Cell Lung Cancer - Pipeline Review, H1 2020
Small-Cell Lung Cancer - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-...
Published: Jun-2020 | No. of Pages: 1397
|
$ 2000 | |
| Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2020
Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeli...
Published: Jun-2020 | No. of Pages: 627
|
$ 2000 | |
| Myelodysplastic Syndrome - Pipeline Review, H1 2020
Myelodysplastic Syndrome - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myel...
Published: Jun-2020 | No. of Pages: 1667
|
$ 2000 | |
| Bladder Cancer - Pipeline Review, H1 2020
Bladder Cancer - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer...
Published: Jun-2020 | No. of Pages: 1855
|
$ 2500 | |
| Macular Edema - Pipeline Review, H1 2020
Macular Edema - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Macular Edema -...
Published: Jun-2020 | No. of Pages: 92
|
$ 2000 | |
| Retinal Vein Occlusion - Pipeline Review, H1 2020
Retinal Vein Occlusion - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retina...
Published: Jun-2020 | No. of Pages: 93
|
$ 2000 | |
| Radiodermatitis - Pipeline Review, H1 2020
Radiodermatitis - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiodermatit...
Published: Jun-2020 | No. of Pages: 57
|
$ 2000 |